MedTrace Logo

CAVA: Dizziness Trial

NCT04026516 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-12-22

No results posted yet for this study

Summary

Clinical investigation of a medical device (CAVA) for recording eye movements. Patients suffering from diagnosed dizziness conditions will wear the device for 23 hours a day, for 30 days. The device will capture normal eye movement data as well as data corresponding to any dizzy events experienced. At the end of the trial, the data will be downloaded and a scientist will perform a blinded analysis of the data. Specifically, they will attempt to identify the dates on which dizziness was reported.

Conditions

  • Meniere's Disease
  • Benign Paroxysmal Positional Vertigo
  • Recurrent Vestibulopathy
  • Vestibular Migraine

Interventions

DEVICE

CAVA Device

The CAVA device will be worn continuously for thirty days, during which time it will record eye and head movements

Sponsors & Collaborators

  • University of East Anglia

    collaborator OTHER

  • Julie Dawson

    lead OTHER

Principal Investigators

  • John Phillips, Consultant · Dr

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04026516 on ClinicalTrials.gov